U.S. lawmakers tussle over generic biologic drugs
(Reuters)
Unusual Little Blurbs
Reuters - U.S. lawmakers tussled on Thursday over how long makers of biotechnology drugs should have an exclusive license for the expensive medicines in a hearing called to discuss a Federal Trade Commission report on the issue.
Source: Yahoo! News: Biotechnology News